Document Detail

Balloon angioplasty for obstructed modified systemic-pulmonary artery shunts and pulmonary artery stenoses.
MedLine Citation:
PMID:  11693774     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: The results of percutaneous balloon angioplasty for obstructed modified Blalock-Taussig (BT) or central shunts and pulmonary artery (PA) stenoses were studied to assess its role as an alternative to second shunt and surgical PA angioplasty. BACKGROUND: Obstruction of a modified shunt and PA stenosis related to the shunt or ductus are not infrequent. A second shunt with or without PA angioplastv is required if the PA size, morphology or age of the patient is suboptimal for definitive surgery. METHODS: From June 1994 to May 1999, balloon angioplasty for obstructed systemic-to-PA shunts was performed in 46 patients, with ages ranging from 1 month to 7.4 years (2.2 +/- 1.9 years). Among the 46 patients, 32 had modified BT shunts, 5 had bilateral shunts, 7 had modified central shunts, and 2 had both modified BT and central shunts. Stenoses were seen in 27 main branch PAs, and interruption was present in three. A concurrent balloon angioplasty was attempted in 28 main branch PAs, but it was performed in only 25 vessels. RESULTS: Balloon dilation for obstructed modified shunts was considered to be effective in 42 patients (91%), while angioplasty for PA stenosis was effective in 14 vessels and not effective in 11 vessels. After balloon dilation angioplastv, oxygen saturation in the aorta increased from 74.4 +/- 4.3% to 80.8 +/- 3.6% (p < 0.01) in these 46 patients. One patient died of pneumonia. Eight patients required an additional modified BT shunt soon after the procedure because of severe stenosis or interruption at main branch PA. After a mean follow-up period of 11.6 +/- 5.4 months, 29 patients underwent a repeated imaging study to evaluate the morphology and size of the PAs. Of these 29 patients, 26 underwent open-heart surgery, with two mortalities. CONCLUSIONS: When a second shunt is under consideration because of obstruction of the modified shunt, balloon angioplasty is a possible alternative procedure. Pulmonary artery stenosis, if present, can be simultaneously dilated.
J K Wang; M H Wu; C I Chang; I S Chiu; H C Lue
Related Documents :
21961014 - One-stage combined thoracic ancient schwannomas total removal and coronary artery bypass.
1169754 - Pulmonary valvular dysfunction in children with ventriculovenous shunts for hydrocephal...
2304324 - A modified technique for the production of an arterio-venous shunt in sheep, allowing a...
12221424 - Intrapulmonary arteriovenous shunt: diagnosis by saline contrast bubbles in the pulmona...
10527444 - Algorithm for the diagnosis and treatment of endoleaks.
14578704 - Scintigraphic probability and angiographic diagnostic certainty in acute pulmonary embo...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  37     ISSN:  0735-1097     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  2001 Mar 
Date Detail:
Created Date:  2001-11-05     Completed Date:  2001-12-04     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  940-7     Citation Subset:  AIM; IM    
Department of Pediatrics, National Taiwan University Hospital, Taipei.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Balloon*
Blood Vessel Prosthesis Implantation*
Child, Preschool
Constriction, Pathologic
Graft Occlusion, Vascular / therapy*
Infant, Newborn
Pulmonary Artery / pathology*
Subclavian Artery / radiography
Comment In:
J Am Coll Cardiol. 2001 Mar 1;37(3):948-50   [PMID:  11693775 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The Fontan procedure for tricuspid atresia: early and late results of a 25-year experience with 216 ...
Next Document:  alpha-Methylnorepinephrine, a selective alpha2-adrenergic agonist for cardiac resuscitation.